The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was Delete all. DO11.10 (talk) 04:12, 29 November 2007 (UTC)[reply]

Ananeuzumab[edit]

Ananeuzumab (edit | talk | history | protect | delete | links | watch | logs | views) – (View log)

Per discussion on WT:PHARM (see WT:PHARM#Tiratumumab and WT:PHARM#Assessment), this and the 62 articles below, all on therapeutic monoclonal antibodies, have been assessed by myself, Paul gene (talk · contribs), and StephP (talk · contribs), and found to be unverifiable by publicly-available sources. While compounds with these names may even exist, we were unable to find reliable sources which could be used to expand or cite them. Their creator, Blake3522 (talk · contribs), has not yet responded to a note left on his Talk asking about sources he may have used. Delete all. Fvasconcellos (t·c) 16:41, 28 November 2007 (UTC)[reply]

Anergrozumab (edit | talk | history | protect | delete | links | watch | logs | views)
Anrulizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Azulizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Balizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Belizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Betumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cetforlimumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cetinlimumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cetlalimumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cetolimumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cidfusituzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cidtuzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Citilimumab (edit | talk | history | protect | delete | links | watch | logs | views)
Cynosumab (edit | talk | history | protect | delete | links | watch | logs | views)
Destilimumab (edit | talk | history | protect | delete | links | watch | logs | views)
Doraglizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Dorlizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Drinalizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Durlizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Epkizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Extumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Futumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Genosumab (edit | talk | history | protect | delete | links | watch | logs | views)
Hylizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Intumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Lucalizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Matenazumab (edit | talk | history | protect | delete | links | watch | logs | views)
Nolovizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Numavizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Oteliximab (edit | talk | history | protect | delete | links | watch | logs | views)
Pecfusituzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Pectuzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Quartuzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Quetumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Ralivizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Resatumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Reslivizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Restumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Resyvizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Rilotumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Rosutumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Synosumab (edit | talk | history | protect | delete | links | watch | logs | views)
Talineuzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Taneuzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tanirazumab (edit | talk | history | protect | delete | links | watch | logs | views)
Teglizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tilolizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tiratumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tolizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tralizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Treglizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Trelizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Trilizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tritumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Trixatumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Tucusituzumab (edit | talk | history | protect | delete | links | watch | logs | views)
Ubrelizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Umavizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Valtumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Vexatumumab (edit | talk | history | protect | delete | links | watch | logs | views)
Xalizumab (edit | talk | history | protect | delete | links | watch | logs | views)
Zulizumab (edit | talk | history | protect | delete | links | watch | logs | views)
well, he should get a job composing usans--or is that done by computer these days? I see there are apparently another 120 or so still being checked a the project--the ones that happen to have matched. This group are just the ones without any matches at all. I think that's clear enough for a speedy close.DGG (talk) 03:36, 29 November 2007 (UTC)[reply]
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.